Prime Medicine, Inc. - COMMON STOCK (PRME)

CUSIP: 74168J101

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / COMMON STOCK
Shares outstanding
181,672,212
Total 13F shares
92,347,818
Share change
+33,667,998
Total reported value
$511,536,971
Put/Call ratio
71%
Price per share
$5.54
Number of holders
165
Value change
+$186,859,809
Number of buys
115
Number of sells
37

Quarterly Holders Quick Answers

What is CUSIP 74168J101?
CUSIP 74168J101 identifies PRME - Prime Medicine, Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of PRME - Prime Medicine, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
GV 2019 GP, L.L.C.
3/4/5
10%+ Owner
class O/S missing
11,862,498
$177,594,643 20 Jun 2023
FMR LLC
3/4/5 13D/G 13F
Other* · Company
3.8%
from 13D/G
8,462,946
$126,699,612 24 Oct 2022
GV 2019, L.P.
13D/G
Alphabet Holdings LLC
12%
16,562,498
$91,756,239 $0 30 Sep 2025
ARCH Venture Fund XII, L.P.
13D/G
Robert Nelsen
10%
18,587,036
$80,853,607 $0 07 Aug 2025
Robert Nelsen
3/4/5
Director, 10%+ Owner
mixed-class rows
18,547,974
mixed-class rows
$73,946,120 +$9,999,990 01 Aug 2025
ARCH Venture Partners X, LLC
3/4/5
10%+ Owner
10%
18,486,894
$73,876,172 +$9,999,990 01 Aug 2025
ARCH Venture Partners XII, LLC
3/4/5
10%+ Owner
10%
18,486,894
$73,876,172 +$9,999,990 01 Aug 2025
David R. Liu
3/4/5
10%+ Owner
11%
20,240,945
$50,920,145 +$163,017 30 Jun 2025
Alphabet Inc.
13F
Company
8.3%
15,062,498
$37,204,370 30 Jun 2025
13F
GV 2023 GP, L.L.C.
3/4/5
Member of 10% Group
class O/S missing
3,200,000
$20,000,000 20 Feb 2024
Keith Michael Gottesdiener
3/4/5
Exhibit 24 - Power of Attorney; Title: President and Chief Executive Officer, Director
mixed-class rows
3,343,337
mixed-class rows
$19,020,856 08 May 2025
T. Rowe Price Investment Management, Inc.
13F
Company
3.6%
6,484,787
$16,018,000 30 Jun 2025
13F
BlackRock, Inc.
13F
Company
2.5%
4,485,828
$11,079,995 30 Jun 2025
13F
GV 2021 GP, L.L.C.
3/4/5
10%+ Owner
1.8%
3,262,440
$10,766,052 +$4,950,000 01 Aug 2025
Newpath Partners, L.P.
13D/G
4.7%
6,105,679
$9,769,086 $0 31 Dec 2024
VANGUARD GROUP INC
13F
Company
2%
3,627,510
$8,959,950 30 Jun 2025
13F
ARK Investment Management LLC
13F
Company
1.3%
2,322,669
$5,736,992 30 Jun 2025
13F
Redmile Group, LLC
13F
Company
1.1%
2,074,350
$5,123,645 30 Jun 2025
13F
MWG Management Ltd.
13F
Company
0.99%
1,792,210
$4,426,759 30 Jun 2025
13F
Sumitomo Mitsui Trust Group, Inc.
13F
Company
0.88%
1,594,518
$3,938,459 30 Jun 2025
13F
Amova Asset Management Americas, Inc.
13F
Company
0.87%
1,589,117
$3,893,337 30 Jun 2025
13F
Casdin Capital, LLC
13F
Company
0.86%
1,567,175
$3,870,922 30 Jun 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.83%
1,510,749
$3,732,447 30 Jun 2025
13F
STATE STREET CORP
13F
Company
0.68%
1,239,337
$3,061,162 30 Jun 2025
13F
Greenwich Wealth Management LLC
13F
Company
0.47%
846,201
$2,090,000 30 Jun 2025
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.45%
818,518
$2,021,736 30 Jun 2025
13F
FARALLON CAPITAL MANAGEMENT LLC
13F
Company
0.41%
750,000
$1,852,500 30 Jun 2025
13F
MORGAN STANLEY
13F
Company
0.32%
587,676
$1,451,561 30 Jun 2025
13F
CITADEL ADVISORS LLC
13F
Company
0.29%
521,508
$1,288,124 30 Jun 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.29%
518,628
$1,281,011 30 Jun 2025
13F
NORTHERN TRUST CORP
13F
Company
0.28%
512,234
$1,265,217 30 Jun 2025
13F
MOORE CAPITAL MANAGEMENT, LP
13F
Company
0.28%
500,000
$1,235,000 30 Jun 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.27%
482,728
$1,192,338 30 Jun 2025
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.23%
424,355
$1,048,157 30 Jun 2025
13F
FRED ALGER MANAGEMENT, LLC
13F
Company
0.21%
383,194
$946,489 30 Jun 2025
13F
Bollard Group LLC
13F
Company
0.2%
361,136
$892,000 30 Jun 2025
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.14%
258,423
$638,305 30 Jun 2025
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.12%
223,400
$551,798 30 Jun 2025
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.12%
214,800
$530,556 30 Jun 2025
13F
CHELSEA COUNSEL CO
13F
Company
0.11%
208,210
$514,279 30 Jun 2025
13F
Nuveen, LLC
13F
Company
0.11%
207,894
$513,498 30 Jun 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.11%
207,008
$511,310 30 Jun 2025
13F
UBS Group AG
13F
Company
0.11%
195,327
$482,458 30 Jun 2025
13F
SIMPLEX TRADING, LLC
13F
Company
0.11%
193,615
$478,000 30 Jun 2025
13F
Palumbo Wealth Management LLC
13F
Company
0.1%
183,358
$452,895 30 Jun 2025
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.09%
167,420
$413,527 30 Jun 2025
13F
Bank of New York Mellon Corp
13F
Company
0.09%
162,052
$400,267 30 Jun 2025
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.08%
147,996
$365,550 30 Jun 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.08%
144,511
$356,943 30 Jun 2025
13F
LEVIN CAPITAL STRATEGIES, L.P.
13F
Company
0.08%
140,000
$345,800 30 Jun 2025
13F

Institutional Holders of Prime Medicine, Inc. - COMMON STOCK (PRME) as of Q3 2025

As of 30 Sep 2025, Prime Medicine, Inc. - COMMON STOCK (PRME) was held by 165 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 92,347,818 shares. The largest 10 holders included Alphabet Inc., T. Rowe Price Investment Management, Inc., BlackRock, Inc., ARK Investment Management LLC, VANGUARD GROUP INC, FARALLON CAPITAL MANAGEMENT LLC, Sumitomo Mitsui Trust Group, Inc., Amova Asset Management Americas, Inc., Casdin Capital, LLC, and Woodline Partners LP. This page lists 165 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
118
Q3 2025 holders
165
Holder diff
47
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 Value $ Q3 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .